Candidiasis Therapeutics Market- Growth, Trends, and Forecast (2019 - 2024)

The Market is segmented by Route of Administration (Injection, Ointment and Oral), Drug Type, Anatomy Type, Distribution Channel and Geography

Market Snapshot

Candidiasis Therapeutics Market_image1
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

5.5%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The candidiasis therapeutics market is expected to witness rapid growth due to the increase in the number of patients affected by candidiasis infection, increasing susceptible immune compromised patient pool and growing awareness for candidiasis infection.

There has been an increase in the number of patients affected by candidiasis infection in the developing markets that is expected to boost the overall market growth over the forecast period. The Center for Disease Control and Prevention (CDC) estimates that approximately 46,000 cases of healthcare-associated invasive candidiasis occur each year, in the United States. CDC reports that the 30-day all-cause (crude) mortality among people with candidemia is approximately 30%. However, as people who develop invasive candidiasis typically have pre-medical conditions, it is generally ambiguous to determine the proportion of deaths directly attributable to the infection. This increase in the number of patients has helped in spurring the growth of the overall market. The increasing of the urbanization and rising hygiene awareness in the developing countries also helps in the growth of the market.

Scope of the Report

As per the scope of the report, candidiasis is commonly a fungal infection that affects men and women both of all age groups. It is also known as candidosis, moniliasis, and oidiomycosis. The effects of this infection are seen on a dermal, internal and systemic level wherein it is known as candidemia or intestinal thrush. The market is dynamic due to widespread occurrence of this disease. The major drug classes for treatment include azoles, polyenes and echinocandins.

By Route of Administration
Injection
Ointment
Oral
By Drug Type
Polyene
Azole
Echinocandin
Others
By Anatomy Type
Oral Candidiasis
Vulvovaginal Candidiasis
Cutaneous Candidiasis
Invasive Candidiasis
Systemic Candidiasis
By Distribution Channel
Hospitals
Clinics
Retail Pharmacies
Drug Stores
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Systemic Candidiasis is Anticipated to be the Dominant Segment in Anatomy Type During the Forecast Period

The market for systemic candidiasis is found to be driven by the increase in the susceptible immune compromised patient pool. Thrush occurs in approximately 2–5 percent of healthy newborn and affects them mainly during their first year of life. Over 1 million adult women and adolescent girls in the US develop vaginal yeast infections each year. Therefore the high incidence of candidiasis is expected to remain a major driver for the growth of the market during the forecast period.

Candidiasis Therapeutics Market_image2

To understand key trends, Download Sample Report

North America Region Holds the Largest Market Share of Candidiasis Therapeutics Market

Due to high investment in healthcare and awareness of diseases, the North American segment of the market studied is estimated to account for the highest market share. The candidiasis disease is found growing rapidly in US and is not restricted to any particular region. It has also been found that the North America and Europe region has been account for the largest markets revenue share due to higher awareness of the disease amongst individuals and also availability of better treatment. Hence all these factors are associated with the growth of the market.

Candidiasis Therapeutics Market_image3

To understand geography trends, Download Sample Report

Competitive Landscape

The major companies present in the market are found focusing on product innovations, expansions, finding new markets or innovating their core competency to expand their individual market share.

Major Players

  1. Basilea Pharmaceuticals
  2. Astellas
  3. Ferrer Internacional
  4. Pacgen Biopharmaceuticals
  5. NovaDigm Therapeutics

* Complete list of players covered available in the table of contents below

Candidiasis Therapeutics Market_image4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Number of Patients Affected by Candidiasis Infection

      2. 4.2.2 Growing Awareness for Candidiasis Infection

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Alternative Treatments

      2. 4.3.2 Narrow Pipeline Molecules

      3. 4.3.3 Competition from Herbal Medicines and Alternate Therapies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Route of Administration

      1. 5.1.1 Injection

      2. 5.1.2 Ointment

      3. 5.1.3 Oral

    2. 5.2 By Drug Type

      1. 5.2.1 Polyene

      2. 5.2.2 Azole

      3. 5.2.3 Echinocandin

      4. 5.2.4 Others

    3. 5.3 By Anatomy Type

      1. 5.3.1 Oral Candidiasis

      2. 5.3.2 Vulvovaginal Candidiasis

      3. 5.3.3 Cutaneous Candidiasis

      4. 5.3.4 Invasive Candidiasis

      5. 5.3.5 Systemic Candidiasis

    4. 5.4 By Distribution Channel

      1. 5.4.1 Hospitals

      2. 5.4.2 Clinics

      3. 5.4.3 Retail Pharmacies

      4. 5.4.4 Drug Stores

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 US

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 UK

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Basilea Pharmaceuticals

      2. 6.1.2 Astellas

      3. 6.1.3 Ferrer Internacional

      4. 6.1.4 Pacgen Biopharmaceuticals

      5. 6.1.5 NovaDigm Therapeutics

      6. 6.1.6 Pevion Biotech

      7. 6.1.7 Amplyx Pharmaceuticals, Inc.

      8. 6.1.8 Biomar Microbial Technologies

      9. 6.1.9 Cidara Therapeutics, Inc.

      10. 6.1.10 Novabiotics Limited

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information